HTM cell cultures were grown to confluence in 35-mm dishes. After infection, the cell monolayer from each well was washed twice with PBS and harvested in 200 μL lysis buffer (150 mM NaCl, 50 mM Tris [pH 7.4], 1 mM EDTA, 1% NP-40, 0.25% deoxycholate, 1× protein inhibitor cocktail; Roche, Indianapolis, IN; 1 mM phenylmethylsulfonyl fluoride [PMSF], and 1 mM NaF) with a cell scraper and incubated on ice for 15 minutes. Cells were disrupted by sonication (Microson Ultrasonic XL2000; Misonix, Farmingdale, NY) equipped with a 2.4 mm microprobe (Misonix) at setting three for five pulses. The sonicate was then centrifuged at 14,000g for 15 minutes at 4°C and pellets used as insoluble fractions. Pellets were solubilized with 100 μL 10× running buffer (1×: 25 mM Tris [pH 8.3] 192 mM glycine, and 0.1% SDS; Bio-Rad Laboratories, Hercules, CA) and stored at −80°C until use. For organ culture, the dissected, perfused TM was washed with PBS, resuspended in 100 μL lysis buffer, and homogenized in a sterile glass microtissue grinder (Kimble-Kontes, Vineland, NJ). Insoluble fractions were then recovered and treated as described for the HTM cells. TM tissues used in these experiments were obtained from anterior segments of the eyes (two male white donors 76 and 77 years of age) that had been perfused for 3 and 4 days, respectively.
Before electrophoresis, proteins extracts were mixed 1:2 (vol/vol) with loading Laemmli buffer (Bio-Rad) containing 5% β-mercaptoethanol and boiled for 5 minutes. Proteins extracts were separated by 15% SDS-PAGE gels and electrotransferred to a PVDF membrane using a mini transblot system (Bio-Rad) and manufacturer’s buffers. After blocking with 5% nonfat dry milk in 0.01 M Tris-HCl (pH 8.0), 0.2% Tween 20 for 2 hours, membranes were incubated overnight at 4°C with a rabbit polyclonal MGP-N
30 (1:1000) or MGP-GLA
30 (1:500). After treatment with anti-rabbit IgG secondary antibodies conjugated to horseradish peroxidase (1:5000; Pierce Biotechnology, Inc, Rockford, IL), immunoreactive bands were visualized by chemiluminescence (ECL Plus; GE Healthcare, Piscataway, NJ) and membranes exposed to light film (BioMax MR; Kodak, Rochester, NY).